SCHEMBL22553933

SCHEMBL22553933

N#Cc1[nH]c2ncccc2c1-c1cncc(-c2ccc(N3CCCC3=O)cc2)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TBK1 Q9UHD2 1/20 0.43
GAA P10253 1/20 0.41
PIM1 P11309 2/20 0.40
ALOX5AP P20292 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
CD38 P28907 1/20 0.36
HPGDS O60760 1/20 0.36
CHEK1 O14757 4/20 0.36
MEN1 O00255 1/20 0.36
TSHR P16473 1/20 0.36
KMT2A Q03164 1/20 0.36
NPC1 O15118 1/20 0.36
CCNC P24863 1/20 0.35
CDK8 P49336 1/20 0.35
DGAT2 Q96PD7 1/20 0.35
DHODH Q02127 1/20 0.35
PDE10A Q9Y233 1/20 0.35
ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30730777 1.00 TBK1 (0.43) TBK1GAAPIM1ALOX5APCYP11B1
SCHEMBL22553948 0.78 CAMKK2 (0.45) GAAPIM1CD38HPGDS
SCHEMBL22553864 0.76 ALOX5AP (0.39) GAAPIM1ALOX5APCYP11B1CYP11B2
SCHEMBL22553727 0.73 ALDH1A1 (0.48) GAACYP11B1CYP11B2CD38CHEK1
SCHEMBL30730791 0.73 ALDH1A1 (0.48) GAACYP11B1CYP11B2CD38CHEK1
SCHEMBL22553859 0.72 PIP4K2A (0.45) GAAPIM1ALOX5APCYP11B1CYP11B2
SCHEMBL22553754 0.72 BRD4 (0.49) GAAPIM1ALOX5APCYP11B1CYP11B2
SCHEMBL30730856 0.72 NUDT1 (0.47) TBK1MEN1TSHRKMT2ADGAT2
SCHEMBL22553994 0.72 RPS6KA3 (0.40) CYP11B2CD38NPC1CCNCCDK8
SCHEMBL30777579 0.72 CYP11B1 (0.60) GAAPIM1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2024-03-05 US claimed
EP-3728230-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS Ravenna Pharmaceuticals, Inc. (US) 2020-10-28 EP claimed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US claimed
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2024-03-05 US disclosed
EP-3728230-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS Ravenna Pharmaceuticals, Inc. (US) 2020-10-28 EP disclosed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US disclosed
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2020-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331913-A1 ARYL-BIPYRIDINE AMINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS PIP5K1A, PIP5K1B, PIP5K1C TBK1 714/4885GAA 1936/4885PIM1 669/4885
US-11919902-B2 Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors PIP5K1A, PIP5K1B, PIP5K1C TBK1 714/4885GAA 1936/4885PIM1 669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.